On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 20, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Mar. 5, 2020, Heat Biologics announced a strategic collaboration with the University of Miami Miller School of…
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…